Key facts
- Notable investors include Living Lab Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Increase Laboratorium Indonesia
- ·The full record, as it builds
Funding rounds
No funding rounds for Increase Laboratorium Indonesia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Increase Laboratorium Indonesia
Developer of clinical research infrastructure designed for laboratory testing, trial management, and healthcare innovation. The company's platform integrates centralized bioanalytical laboratories, digital trial coordination tools, and collaborative research networks with academic institutions to support vaccine development, infectious disease studies, and personalized treatment access, enabling hospitals, pharmaceutical companies, and clinical organizations in emerging markets to improve trial feasibility, accelerate research timelines, and expand patient access to advanced medical industry.
- Sector
- Healthcare
- HQ
- Tangerang Regency, Indonesia
- Employees
- 17
- Website
- increase-id.com/
- Ownership
- Privately Held (backing)
Increase Laboratorium Indonesia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Increase Laboratorium Indonesia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Increase Laboratorium Indonesia in its N-PORT filings yet. We sweep new filings monthly.